Close
Nordic 9Nordic 9

OrbiMed Advisors (investor - Others)

United States orbimed.com
See something wrong or missing? Let us know
Offices:New York

OrbiMed is an American healthcare-dedicated hedge fund founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Average round investment:100.35M USD
Average number per year:3.0
Distribution: 2025 (4)2024 (4)2023 (4)2022 (2)2021 (1) See the entire list
Portfolio companies: Ireland ProVerumUnited Kingdom Charm TherapeuticsSwitzerland vVARDIS See the entire list
Mostly invests in: United Kingdom United Kingdom (6) Health services (18)
See the entire list

Showing 3 of 18 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

OrbiMed Advisors mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to OrbiMed Advisors

Name Criteria
Netherlands Gilde Healthcare
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Denmark, France, Ireland, Germany
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
United States Morgan Stanley
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, France, Ireland, Germany
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United Kingdom Cambridge Innovation Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland, Germany
  • Average number of deals per year: 3.4
  • Active last 12 months: Yes
United States Invus
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Denmark, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States New Enterprise Associates
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Denmark, France, Ireland, Germany
  • Average number of deals per year: 3.8
  • Active last 12 months: Yes
United States Bain Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Denmark, France, Germany
  • Average number of deals per year: 4.6
  • Active last 12 months: Yes
United States Spark Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France, Germany
  • Average number of deals per year: 4.9
  • Active last 12 months: Yes
United Kingdom M&G Investments
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Germany
  • Average number of deals per year: 5.0
  • Active last 12 months: Yes
United Kingdom Schroders
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, France
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Switzerland Novartis Venture Fund
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Ireland, Germany
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Top